14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:TSRO
Delisted

TESARO Fund Price (Quote)

$74.96
+0 (+0%)
At Close: Feb 13, 2019

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 13th Feb 2019 TSRO stock ended at $74.96. During the day the stock fluctuated 0% from a day low at $74.96 to a day high of $74.96.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical TESARO prices

Date Open High Low Close Volume
Feb 23, 2016 $39.11 $39.77 $37.26 $37.29 369 500
Feb 22, 2016 $40.20 $40.53 $38.97 $39.38 530 100
Feb 19, 2016 $37.78 $40.09 $37.05 $39.70 448 000
Feb 18, 2016 $39.89 $40.07 $37.92 $38.08 463 200
Feb 17, 2016 $38.72 $41.49 $38.27 $39.74 710 900
Feb 16, 2016 $36.55 $38.27 $35.95 $38.16 435 900
Feb 12, 2016 $35.75 $36.50 $33.90 $36.09 615 200
Feb 11, 2016 $31.37 $35.84 $31.00 $34.96 520 300
Feb 10, 2016 $32.33 $34.21 $32.02 $32.24 705 100
Feb 09, 2016 $31.22 $33.38 $29.51 $32.06 1 329 900
Feb 08, 2016 $34.45 $34.69 $31.24 $32.01 938 600
Feb 05, 2016 $36.80 $37.62 $34.27 $35.49 852 600
Feb 04, 2016 $35.77 $38.00 $35.32 $36.40 486 800
Feb 03, 2016 $35.12 $35.92 $32.50 $35.89 532 300
Feb 02, 2016 $34.93 $35.44 $33.70 $34.94 509 100
Feb 01, 2016 $34.78 $36.06 $33.60 $35.64 507 800
Jan 29, 2016 $34.25 $35.81 $33.25 $34.54 878 000
Jan 28, 2016 $36.25 $36.94 $33.23 $34.46 491 900
Jan 27, 2016 $37.05 $37.82 $34.78 $35.44 544 700
Jan 26, 2016 $38.49 $39.06 $36.41 $37.13 363 100
Jan 25, 2016 $38.41 $39.80 $37.09 $38.13 611 300
Jan 22, 2016 $37.49 $39.57 $36.09 $38.70 561 200
Jan 21, 2016 $37.70 $39.38 $36.31 $36.49 502 200
Jan 20, 2016 $33.84 $38.38 $32.73 $37.30 713 500
Jan 19, 2016 $36.51 $36.99 $34.17 $34.95 675 000
Click to get the best stock tips daily for free!

About TESARO

TESARO, Inc., an oncology-focused biopharmaceutical company, identifies, acquires, develops, and commercializes cancer therapeutics and oncology supportive care products in the United States and internationally. Its product portfolio consist of Rolapitant, a neurokinin-1 receptor antagonist, which is in phase 1 intravenous clinical trials for the prevention of chemotherapy induced nausea and vomiting; Niraparib, an orally active and potent poly p... TSRO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT